Online Submissions: http://www.wjgnet.com/1948-9358office World J Diabetes 2011 June 15; 2(6): 82-91
[email protected] ISSN 1948-9358 (online) doi:10.4239/wjd.v2.i6.82 © 2011 Baishideng. All rights reserved. GUIDELINES FOR BASIC RESEARCH Role of melatonin on diabetes-related metabolic disorders Javier Espino, José A Pariente, Ana B Rodríguez Javier Espino, José A Pariente, Ana B Rodríguez, Department be more sensitive to the actions of melatonin, thereby of Physiology, Neuroimmunophysiology and Chrononutrition leading to impaired insulin secretion. Therefore, block- Research Group, Faculty of Science, University of Extremadura, ing the melatonin-induced inhibition of insulin secretion Badajoz 06006, Spain may be a novel therapeutic avenue for type 2 diabetes. Author contributions: Espino J wrote the manuscript; Pariente JA and Rodríguez AB revised the manuscript critically for important © 2011 Baishideng. All rights reserved. intellectual content; and all authors approve the final version to be published. Supported by Ministry of Education (AP2009-0753, to Dr. Javier Key words: Melatonin; Circadian rhythm; Diabetes; In- Espino) sulin secretion; Pancreatic β-cell; Melatonin receptor Correspondence to: Javier Espino, MSc, Department of Physi- ology, Neuroimmunophysiology and Chrononutrition Research Peer reviewers: Fernando Guerrero-Romero, MD, PhD, FA- Group, Faculty of Science, University of Extremadura, 06006 CP, Medical Research Unit in Clinical Epidemiology of the Badajoz, Spain.
[email protected] Mexican Social Security Institute, Siqueiros 225 esq. Casta_ Telephone: +34-924-289388 Fax: +34-924-289388 eda, 34000 Durango, Durango, México Received: February 14, 2011 Revised: May 20, 2011 Accepted: May 27, 2011 Espino J, Pariente JA, Rodríguez AB. Role of melatonin on Published online: June 15, 2011 diabetes-related metabolic disorders.